Evidence map›Paper›PMID 30800037›Full record

ArticleBreast care (Basel, Switzerland)2018

Clinical Validation of

Manfred Schmitt, Olaf G Wilhelm, Aurelia Noske, Gabriele Schricker, Rudolph Napieralski, Martina Vetter, Michaela Aubele, Jonathan Perkins, Jürgen Lauber, Kurt Ulm and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Breast care (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 3 countries.

Manfred SchmittTherawis Diagnostics GmbH, Munich, Germany.
Olaf G WilhelmTherawis Diagnostics GmbH, Munich, Germany.
Aurelia NoskeInstitute of Pathology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
Gabriele SchrickerTherawis Diagnostics GmbH, Munich, Germany.
Rudolph NapieralskiTherawis Diagnostics GmbH, Munich, Germany.
Martina VetterDepartment of Gynecology, Martin-Luther-Universität Halle-Wittenberg, Halle (Saale), Germany.
Michaela AubeleTherawis Diagnostics GmbH, Munich, Germany.
Jonathan PerkinsQIAGEN Manchester Ltd., Manchester, United Kingdom.
Jürgen LauberQIAGEN GmbH, Hilden, Germany.
Kurt UlmInstitute of Medical Informatics, Statistics and Epidemiology, Technische Universität München, Munich, Germany.
Christoph ThomssenDepartment of Gynecology, Martin-Luther-Universität Halle-Wittenberg, Halle (Saale), Germany.
John W M MartensDepartment of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC, Rotterdam, The Netherlands.
Wilko WeichertInstitute of Pathology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
Marion KiechleDepartment of Obstetrics and Gynecology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
CS Diagnostics · DETUM Klinikum · DEMartin Luther University Halle-Wittenberg · DEErasmus MC · NLQiagen (Germany) · DEQiagen (United Kingdom) · GBTechnical University of Munich · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Breast cancerPITX2 DNA methylationTherapy prediction

Identifiers

PMID30800037
PMCPMC6381917
OpenAlexW2894301969

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.